global teams

9.19.2013 Medical Affairs

Six Steps to Hosting a Successful Pharmaceutical Advisory Board

By Jennifer Harrell, Research Analyst Generations of hopeful party planners and anxious hostesses have turned to Emily Post as the authority on all things etiquette. Her gentle but firm guidelines on manners and social norms may seem more appropriate...
 

7.26.2013 Medical Affairs

Medical Affairs Team Structure: Centralized or Decentralized?

By Yanis Saradjian, Director of Consulting A medical affairs team’s structure is contingent on a number of determining factors.  The growing complexity of the compliance requirements that pharmaceutical and biotechnology companies must adhere...
 

4.29.2013 KOL Management

Driving KOL Engagement Efficiency through Physician-Interaction Databases

Cutting Edge Information recently conducted research among pharmaceutical medical affairs groups that looked at physician-interaction database ownership.  The research revealed that ownership of these databases varies among the surveyed companies.  Global groups...
 

3.4.2013 Market Access

Global Pressures = Pricing Challenges

Over the past few years, political, social and economic upheavals worldwide have thrust change on the life sciences landscape — and forced pricing teams to work overtime.  Today, these teams must deal with a series of events and trends that each have some effect...
 

2.5.2013 Market Access

I want THAT price: Understanding the Rationale Behind International Price Referencing

Growing up, siblings have an unspoken rule that  if one received something or was allowed to do something that another wasn’t, instantly, life became “unfair” for the other party.  The smaller the age differential between the siblings, the more unfair the...
 

11.14.2012 Medical Affairs

Medical Science Liaison Teams Expanding in Europe and Asia

A recent study on medical science liaison (MSL) teams analyzes the global expansion of this key slice of medical affairs operations. Until recently, pharmaceutical and medical device companies have largely focused their MSL teams on the US market, with a small...
 

10.16.2012 Regulatory Affairs

Wanted: Experienced Regulatory Affairs Personnel

Our recent research suggests intensifying competition among pharmaceutical companies for capable regulatory affairs employees. In fact, experienced regulatory affairs personnel can be counted as a white hot commodity right now. Executives that I have talked with...
 

9.20.2012 Managed Care Liaison / HOL

Moving Toward Health Outcomes Liaisons: Comparison of MSL and HOL Compensation Reflects an Industry Shift

Traditionally, health outcomes liaisons (HOLs) and medical science liaisons (MSLs) represent two different areas of expertise. Both jobs serve an important role: to provide an educational connection between industry leaders and key stakeholders. The former serves...
 

8.7.2012 Medical Affairs

The Global Expansion of Medical Science Liaisons

Significant changes to medical science liaisons’ roles and expectations in the past 15 years have underscored the value MSLs bring to their organizations. MSLs not only provide access to highly influential physicians and medical researchers, but they also bring...
 

8.2.2012 Regulatory Affairs

More Regulations, More Problems

More regulations, more problems. It’s not exactly a catchphrase yet, but it is something you might have overheard within a pharmaceutical regulatory affairs office over the past several years. The simple fact is that over the past five to ten years, guidances...